In a recent settlement agreement, Johnson & Johnson (J&J) reached a significant milestone in its ongoing legal battles by agreeing to a $700 million settlement agreement with a coalition of attorneys general representing 43 U.S. states. The attorneys general had accused the pharmaceutical giant of deceptively marketing its talc-based baby powder, which has been linked to mesothelioma and ovarian cancer.
This particular lawsuit was filed on behalf of consumers who were misled by J&J’s advertising of its talcum powder products. The lawsuit is different from the over 61,000 pending claims filed by individual claimants of mesothelioma and ovarian cancer. According to the attorneys’ general claim, J&J had, for many years, deceptively marketed its products to women and teenage girls as safe, pure, and gentle for use, despite knowing that studies and other evidence, including internal information, suggested that the products contained carcinogenic asbestos. The lawsuit accused J&J of promoting the products as safe and pure despite knowing about the health effects of asbestos.
On top of being required to pay $700 million, the settlement agreement includes several terms that are aimed at protecting the residents of the 43 states. The following are the conditions that J&J agreed to;